Clinical Trials Directory

Trials / Completed

CompletedNCT01465711

The Value of PSP in Predicting Outcome in ICU Surgical Peritonitis Patients

Diagnostic Accuracy of Pancreatic Stone Protein in Predicting Severe Outcome in Patients With Peritonitis at the Intensive Care Unit

Status
Completed
Phase
Study type
Observational
Enrollment
137 (actual)
Sponsor
University of Magdeburg · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the diagnostic accuracy of Pancreatic Stone Protein (PSP) in predicting patient outcomes with suspected peritonitis in the Intensive Care Unit after abdominal surgery and compare PPS with other blood parameters, including C-Reactive Protein (CRP), White Cell Count (WCC), Interleucin-6 (IL-6) and Procalcitonin (PCT).

Detailed description

Peritonitis is a severe complication after abdominal surgery. Patients admitted at the Intensive Care Unit (ICU) following surgery bear the risk of localized infection, sepsis or septic shock. Prevention or early detection of such events is important to intervene with an appropriate therapeutic action and avoid risking a potentially life-threatening situation. White blood cell counts (WCC) and C-Reactive Protein (CRP), Interleucin-6 (IL-6) and Procalcitonin (PCT) have all been promising parameters, however, they are useful only in selective cases and have a limited diagnostic accuracy.

Conditions

Interventions

TypeNameDescription
PROCEDUREAll abdominal surgical proceduresLaparotomy, Laparoscopy
PROCEDUREIntubationVentilatory support
RADIATIONImagingAbdominal ultrasound Computer Tomography Magnetic Resonance Imaging

Timeline

Start date
2007-07-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2011-11-07
Last updated
2014-12-03

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01465711. Inclusion in this directory is not an endorsement.